Stingray Therapeutics
PrivateLast Round
Grant
Nov 15, 2023
Est. Valuation
$37M
Total Funding Raised
$33.96M
Company Overview
Stingray Therapeutics is a biotechnology company that develops immunotherapies designed to treat various types of cancer by targeting the innate immune system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stingray Therapeutics Comparables
Compare Stingray Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Riboscience | 93% | |
| TXINNO Bioscience INC | 87% | |
| ImmuneSensor Therapeutics | 86% | |
Stingray Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Seed | Jan 23, 2023 | ||||
| Grant | Oct 14, 2022 | ||||
| Seed | Apr 5, 2022 | ||||
| Pre Seed | Aug 13, 2020 | ||||
Accelerator | Aug 29, 2018 |
Stingray Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Catalytic Impact Foundation | Seed |
| Cancer Prevention and Research Institute of Texas | Grant |
| Green Park & Golf Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 15, 2023
Secured $14M in grant funding.
- Jan 23, 2023
$3M round completed.
Stingray Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stingray Therapeutics's valuation, stock price, and market status.